Both in Pharmaceuticals
Celularity vs Filana Therapeutics
Over the past year CELU returned −42.0% and FLNA returned −23.1%; their daily moves had a correlation of 0.03.
CELU −42.0% FLNA −23.1%Growth of $1, one year, split-adjusted
| Metric | CELU | FLNA |
|---|---|---|
| Price | $0.8171 | $0.5943 |
| Market cap | $26.5M | $28.7M |
| Today | +1.82% | +5.94% |
| 1 month | −52.2% | −31.7% |
| 6 months | −14.3% | — |
| Year to date | −26.4% | — |
| 1 year | −58.1% | — |
| Revenue growth (YoY) | −5.3% | — |
| Gross margin | 56.8% | — |
| Net margin | 10.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | — |
| Net cash | -$37.1M | $82.7M |
| Dividend yield | — | — |
| Volatility (60d) | 223.1% | — |
| Short % of float | 6.7% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).